Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,905 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Phase 1, Randomized, Open-Label, Safety, Tolerability, and Comparative Bioavailability Study of Intranasal Dihydroergotamine Powder (STS101), Intramuscular Dihydroergotamine Mesylate, and Intranasal DHE Mesylate Spray in Healthy Adult Subjects.
Albrecht D, Iwashima M, Dillon D, Harris S, Levy J. Albrecht D, et al. Among authors: harris s. Headache. 2020 Apr;60(4):701-712. doi: 10.1111/head.13737. Epub 2020 Jan 27. Headache. 2020. PMID: 31985049 Free PMC article. Clinical Trial.
PF-06881893 (Nivestym™), a Filgrastim Biosimilar, Versus US-Licensed Filgrastim Reference Product (US-Neupogen®): Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Safety of Single or Multiple Subcutaneous Doses in Healthy Volunteers.
Yao HM, Ottery FD, Borema T, Harris S, Levy J, May TB, Moosavi S, Zhang J, Summers M. Yao HM, et al. Among authors: harris s. BioDrugs. 2019 Apr;33(2):207-220. doi: 10.1007/s40259-019-00343-8. BioDrugs. 2019. PMID: 30900158 Free PMC article. Clinical Trial.
PF-06881894, a Proposed Biosimilar to Pegfilgrastim, Versus US-Licensed and EU-Approved Pegfilgrastim Reference Products (Neulasta®): Pharmacodynamics, Pharmacokinetics, Immunogenicity, and Safety of Single or Multiple Subcutaneous Doses in Healthy Volunteers.
Moosavi S, Borema T, Ewesuedo R, Harris S, Levy J, May TB, Summers M, Thomas JS, Zhang J, Yao HM. Moosavi S, et al. Among authors: harris s. Adv Ther. 2020 Jul;37(7):3370-3391. doi: 10.1007/s12325-020-01387-x. Epub 2020 Jun 10. Adv Ther. 2020. PMID: 32524499 Free PMC article.
A Thorough QT/QTc Study of Clobazam in Healthy Volunteers.
Tolbert D, Gordon J, Harris S, Walzer M, Bekersky I, Reid S. Tolbert D, et al. Among authors: harris s. Clin Ther. 2017 Oct;39(10):2073-2086. doi: 10.1016/j.clinthera.2017.08.020. Epub 2017 Sep 27. Clin Ther. 2017. PMID: 28958437 Clinical Trial.
4,905 results